Masayon, Joriana Ishiend .
HRN: 23-15-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2023
MUPIROCIN 2%, 15G (TUBE)
06/12/2023
06/19/2023
TOPICAL
Apply On Affected Site
BID
Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes